Sherman Oaks, CANCT07758140Now EnrollingIRB Ready

HPV Clinical Trial in Sherman Oaks, CA

Access cutting-edge hpv treatment through this clinical trial at a research site in Sherman Oaks. Study-provided care at no cost to qualified participants.

Sponsored by Mel Mont Medical

Quick Self-Assessment

See if you qualify for this Sherman Oaks location

Preparing your pre-screening questions…

Expert Care in Sherman Oaks

Access hpv specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hpv treatment provided free

Apply for This Sherman Oaks Location

Check if you qualify for this hpv clinical trial in Sherman Oaks, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Sherman Oaks

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Sherman Oaks site if eligible
  4. 4Begin participation

About This HPV Study in Sherman Oaks

To evaluate whether individuals drawn from the intended use population can successfully interpret and follow the IFU for the Mia by XytoTest self-collection device and perform a vaginal sample collection yielding sufficient cellular material for primary hrHPV screening. To assess the clinical performance of Mia self-collected vaginal specimens by evaluating agreement with paired clinician-collected cervical specimens for the detection of high-risk HPV, when both specimen types are analyzed using the cobas HPV Test (Roche Molecular Systems). Residual samples may be used to determine adequacy for additional assays that require vaginal and/or cervical specimens (such as mRNA E6 and E7 Biomarker Test, dual stain cytology).

Sponsor: Mel Mont Medical

Who Can Participate

Inclusion Criteria

Group 1: General Population Group
Participants are 25 to 65 years of age and willing to provide informed consent.
Participants have an intact cervix. Group 2: Enriched Population Group
Participants are 25 to 65 years of age and willing to provide informed consent.
Participants have an intact cervix.
One or more of: prior diagnosis of hrHPV within previous 6 months; abnormal cervical Pap cytology result of HSIL or higher (HSIL, AIS, or invasive carcinoma per the Bethesda 2014 system) within previous 6 months; and/or presenting for colposcopy/LEEP/excisional intervention.

Exclusion Criteria

Apply to all groups:
Impaired decision-making capacity or inability to provide informed consent.
History of partial or total hysterectomy, including removal of the cervix.
Cervical tissue alteration or surgery within 5 months prior (conization, LEEP, laser ablation, or cryotherapy).
Current pregnancy (based on self-reporting).
Active menstruation at time of specimen collection.
Vaginal bleeding within 48 hours.
Have had sex or used tampons, creams, or other vaginal products in the last 48 hours.
Participation in another clinical study that, in the investigator's opinion, would interfere with the results of this study.
Any medical reason that, in the investigator's opinion, would disqualify the participant for a routine pelvic exam with cervical sample collection.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Sherman Oaks?

Yes, this clinical trial (NCT07758140) has an active research site in Sherman Oaks, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HPV Treatment Options in Sherman Oaks, CA

If you're searching for hpv treatment options in Sherman Oaks, CA, this clinical trial (NCT07758140) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Sherman Oaks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hpv specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hpv clinical trials near you to find additional studies recruiting in your area.

More Cervical Cancer Trials in Sherman Oaks, CA

See all cervical cancer clinical trials recruiting in Sherman Oaks — not just this study.

Browse Cervical Cancer Trials in Sherman Oaks →

Ready to Join in Sherman Oaks?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Sherman Oaks, CA